How big is Nano-X Imaging Ltd.?

As of Jun 18, Nano-X Imaging Ltd. has a market capitalization of 322.64 million, with net sales of 11.55 million and a net profit loss of 54.52 million over the latest four quarters. The company's shareholder's funds were 189.12 million, and total assets amounted to 210.00 million.

As of Jun 18, Nano-X Imaging Ltd. has a market capitalization of 322.64 million, categorizing it as a Micro Cap company.<BR><BR>As of Jun 18, the company reported net sales of 11.55 million for the latest four quarters. During the same period, it experienced a net profit loss of 54.52 million.<BR><BR>As of Dec 24, the company's shareholder's funds were 189.12 million, and its total assets amounted to 210.00 million.

What does Nano-X Imaging Ltd. do?

Nano-X Imaging Ltd. is an Israel-based company that develops a digital X-ray source aimed at reducing imaging system costs. As of March 2025, it reported net sales of $3 million and a net loss of $13 million, with a market cap of $322.64 million.

Overview: <BR>Nano-X Imaging Ltd is an Israel-based company that develops a digital X-ray source enabling a cost reduction of imaging systems, operating within the Pharmaceuticals & Biotechnology industry and classified as a micro-cap company.<BR><BR>Financial Snapshot: <BR>Most recent Net Sales: 3 Million (Quarterly Results - Mar 2025) <BR>Most recent Net Profit: -13 Million (Quarterly Results - Mar 2025) <BR>Market-cap: USD 322.64 Million (Micro Cap)<BR><BR>Key Metrics: <BR>P/E: NA (Loss Making) <BR>Industry P/E: NA <BR>Dividend Yield: 0.00% <BR>Debt Equity: -0.33 <BR>Return on Equity: -30.77% <BR>Price to Book: 1.82<BR><BR>Contact Details: <BR>Address: Communications Center, NEVE 'ILAN None: 9085000

Should I buy, sell or hold Nano-X Imaging Ltd.?

Is Nano-X Imaging Ltd. overvalued or undervalued?

As of March 31, 2022, Nano-X Imaging Ltd. is considered risky and overvalued due to negative performance metrics, including a non-applicable P/E ratio, an EV to EBITDA of -6.41, a ROCE of -48.61%, and a year-to-date stock return of -31.25% compared to the S&P 500's 2.44%.

As of 31 March 2022, the valuation grade for Nano-X Imaging Ltd. has moved from does not qualify to risky. The company appears to be overvalued given its significant negative performance metrics, including a P/E ratio that is not applicable due to losses, an EV to EBITDA ratio of -6.41, and a ROCE of -48.61%. <BR><BR>When compared to peers, Nano-X Imaging's EV to EBITDA ratio of -5.75 significantly underperforms against IRadimed Corp., which has a fair valuation with an EV to EBITDA of 29.31. Other risky peers like Castle Biosciences, Inc. and Mesa Laboratories, Inc. also show concerning metrics, with EV to EBITDA ratios of 9.49 and 16.15, respectively. The company's stock has underperformed relative to the S&P 500, with a year-to-date return of -31.25% compared to the index's 2.44%, reinforcing the notion that Nano-X Imaging Ltd. is currently overvalued.

Is Nano-X Imaging Ltd. technically bullish or bearish?

As of August 12, 2025, Nano-X Imaging Ltd. is in a bearish trend, indicated by multiple technical signals, including a bearish MACD and moving averages, despite a bullish RSI on the monthly time frame, and has significantly underperformed the S&P 500 with a year-to-date return of -42.22%.

As of 12 August 2025, the technical trend for Nano-X Imaging Ltd. has changed from mildly bearish to bearish. The current technical stance is bearish, with key indicators supporting this view including a bearish MACD on the weekly time frame, bearish moving averages on the daily time frame, and a bearish KST on both weekly and monthly time frames. The Bollinger Bands are also indicating a mildly bearish trend on both weekly and monthly time frames. <BR><BR>Despite a bullish RSI on the monthly time frame, the overall sentiment remains bearish due to the predominance of bearish signals across multiple indicators. In terms of performance, the stock has underperformed significantly compared to the S&P 500, with a year-to-date return of -42.22% versus the S&P 500's 12.22%, and a one-year return of -33.55% compared to the S&P 500's 17.14%.